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Objectives: This randomized clinical trial analyzed the long-term (5-year) crestal bone 
changes and soft tissue dimensions surrounding implants with an internal tapered 
connection placed in the anterior mandibular region at different depths (equi- and 
subcrestal).
Materials and methods: Eleven edentulous patients were randomly divided in a split-
mouth design: 28 equicrestal implants (G1) and 27 subcrestal (1–3 mm) implants 
(G2). Five implants were placed per patient. All implants were immediately loaded. 
Standardized intraoral radiographs were used to evaluate crestal bone (CB) changes. 
Patients were assessed immediately, 4, 8, and 60 months after implant placement. The 
correlation between vertical mucosal thickness (VMT) and soft tissue recession was 
analyzed. Sub-group analysis was also performed to evaluate the correlation between 
VMT and CB loss. Rank-based ANOVA was used for comparison between groups 
(α = .05).
Results: Fifty-five implants (G1 = 28 and G2 = 27) were assessed. Implant and 
prosthetic survival rate were 100%. Subcrestal positioning resulted in less CB loss 
(−0.80 mm) when compared to equicrestal position (−0.99 mm), although the differ-
ence was not statistically significant (p > .05). Significant CB loss was found within 
the G1 and G2 groups at two different measurement times (T4 and T60) (p < .05). 
Implant placement depths and VMT had no effect on soft tissue recession (p > .05).
Conclusions: There was no statistically significant difference in CB changes between 
subcrestal and equicrestal implant positioning; however, subcrestal position resulted 
in higher bone levels. Neither mucosal recession nor vertical mucosa thickness was 
influenced by different implant placement depths.
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1  | INTRODUC TION
Marginal bone loss around dental implants is a common occur-
rence that can be accelerated by surgical trauma during flap eleva-
tion and bone osteotomy for implant placement. In addition, bone 
remodeling occurs during the establishment of the peri-implant 
supracrestal tissue attachment (Berglundh & Lindhe, 1996; Cosyn, 
Sabzevar, & De Bruyn, 2012; Oh, Yoon, Misch, & Wang, 2002; 
Spinato et al., 2019). A current major challenge in implant therapy 
is to minimize crestal bone (CB) loss around implants since this has 
been proven to be essential for soft tissue stability and long-term 
success of the implant treatment (Fu, Lee, & Wang, 2011; Novaes, 
Barros, Muglia, & Borges, 2009; Tarnow, Cho, & Wallace, 2000). 
The implant-abutment interface design and location in relation to 
the bone crest (Koutouzis, Neiva, Nair, Nonhoff, & Lundgren, 2014; 
Romanos, Aydin, Gaertner, & Nentwig, 2015; Vervaeke et al., 2018; 
Weng et al., 2008), the amount of keratinized mucosa (Lin, Chan, & 
Wang, 2013; Perussolo, Souza, Matarazzo, Oliveira, & Araujo, 2018; 
Roccuzzo, Grasso, & Dalmasso, 2016) and soft tissue thickness have 
all been suggested to have a direct impact on implant marginal bone 
loss (Linkevicius, Apse, Grybauskas, & Puisys, 2009; Linkevicius et 
al., 2018; Linkevicius, Puisys, Steigmann, Vindasiute, & Linkeviciene, 
2015; van Eekeren, van Elsas, Tahmaseb, & Wismeijer, 2017). Recent 
studies have also described the role of abutment height in estab-
lishing peri-implant biological distance and as a contributing factor 
toward peri-implant bone changes (Galindo-Moreno et al., 2016; 
Novoa et al., 2017; Spinato et al., 2019).
Implants with an internal taper connection and platform- 
switching can provide better protection against microbial leakage 
and soft tissue inflammation by reducing the microgap at the im-
plant-abutment interface and increasing the distance to the bone 
crest, as well as allowing for a greater amount of connective tissue 
around the implant that functions as a cuff-like barrier (D'Ercole et 
al., 2014; Khorshidi, Raoofi, Moattari, Bagheri, & Kalantari, 2016; 
Lazzara & Porter, 2006; Tenenbaum, Schaaf, & Cuisinier, 2003). The 
subcrestal placement of dental implants may avoid the exposure 
of implant threads after initial physiologic bone remodeling and 
allow an adequate esthetic emergence profile for the prosthetic 
restoration (Koutouzis et al., 2014; Palaska, Tsaousoglou, Vouros, 
Konstantinidis, & Menexes, 2016; Vervaeke et al., 2018). Subcrestal 
implant placement was also suggested to have a positive impact 
on papilla formation and CB preservation (Novaes et al., 2009). 
However, one randomized clinical trial (RCT) with a split-mouth 
design examined platform-switching implants placed sub- and 
equicrestally and concluded that the different implant placement 
depths did not influence CB changes (de Siqueira et al., 2017).
Another factor that can influence marginal bone loss is the fre-
quency of exchange of abutments that may disturb the surround-
ing peri-implant tissues (Rompen, 2012). The “one abutment–one 
time” protocol (use of one definitive abutment at the time of implant 
placement) was introduced to overcome potential sequalae of re-
peated changes of a cover screw or provisional abutments (Canullo, 
Bignozzi, Cocchetto, Cristalli, & Iannello, 2010; Degidi, Nardi, & 
Piattelli, 2011). However, a systematic review on this topic con-
cluded that despite the potential benefits of this approach on mar-
ginal bone level changes, its clinical significance remains uncertain 
(Atieh, Tawse-Smith, Alsabeeha, Ma, & Duncan, 2017).
Indeed, there is still limited information from clinical studies in 
humans on the subcrestal placement of dental implants with plat-
form-switching features, and long-term follow-ups are lacking. This 
randomized controlled trial (RCT) analyzed long-term CB changes 
and soft tissue dimensions surrounding implants with an internal 
tapered connection that were placed in the anterior mandible at dif-
ferent depths (equicrestal and subcrestal) and immediately loaded. 
Clinical and radiographic analyses were performed immediately, 4, 
8, and 60 months after implant placement.
2  | MATERIAL AND METHODS
2.1 | Study population
The study included 11 patients (8 females and 3 males) aged 45 to 
65 years at time of enrollment (mean age: 57.1 years) that received 
implant treatment at the ILAPEO College (ILAPEO, Curitiba, 
PR, Brazil) between 2011 and 2012 with 5 years follow-up. The 
8-month outcomes were reported in a previous study (de Siqueira 
et al., 2017). This study was approved by the ethics committee of 
the State University of Ponta Grossa (UEPG No. 50/2012, Brazil). 
All patients were informed about the evidence-based, positive 
outcome of implant treatment, and the experimental approach of 
implant placement depths that were tested. Each patient received 
verbal as well as written information and signed the informed 
consent.
2.2 | Inclusion criteria
Inclusion criteria were good overall health and fully edentulous 
arches. Within the mandible, each patient had sufficient interfo-
raminal space to allow the placement of five implants with a minimal 
distance of 7 mm between implants (center to center) and minimum 
distance of 3.5 mm from the mental foramen to the most posterior 
implants. Adequate bone height for placement of implants with a 
minimum of 10 mm length and 3.5 mm diameter without simultane-
ous guided bone regeneration was evaluated by means of cone beam 
computed tomography (CBCT).
2.3 | Exclusion criteria
Exclusion criteria were non-controlled diabetes (glycated hemo-
globin (HbA1c) values above 7.5%) (Promsudthi, Pimapansri, 
Deerochanawong, & Kanchanavasita, 2005), immunodeficiencies, 
history of IV bisphosphonate, radiation therapy (up to 5 years before 
the study), heavy smoking (>10 cigarettes/day), and inadequate bone 
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volume for proper implant placement (<10 mm vertical length and 
<5.5 mm ridge width).
2.4 | Presurgical treatment
Treatment allocation is summarized in Figure 1 in accordance with 
the Consolidated Standards of Reporting Trials (CONSORT) criteria 
(Appendix S1). Patients underwent clinical and imaging examination 
(panoramic, cephalometric, and CBCT scan). All patients were reha-
bilitated with maxillary complete dentures and mandibular full-arch 
implant-fixed prostheses (FIFPs). Prior to the surgical procedure, a 
duplication of the lower denture fabricated during treatment plan-
ning was used as the surgical guide. Two implant placement depths—
equicrestal and subcrestal—were tested and randomly assigned to 
each patient under a split-mouth design (i.e., two subcrestal implants 
and three equicrestal implants or vice versa). A researcher not in-
volved with the surgical and prosthetic parts of the study used a 
computer-generated random number table for patient allocation (IS). 
The same researcher secured the random number assigned to each 
patient that was placed in sealed and opaque envelopes.
2.5 | Surgical procedure
Keratinized tissue width (KTW) at the implant placement sites was 
recorded before the surgical procedures by an examiner blinded to 
the treatments provided. The blinded examiner was calibrated for 
better reproducibility of the measurements performed. Vertical mu-
cosa thickness (VMT) was measured at each implant placement site 
using a #30 K-file (Dentsply Maillefer, Ballaigues, Switzerland) that 
was inserted until touching the bone crest. VMT was categorized 
as thin (<2 mm) or thick (≥2 mm) (Linkevicius et al., 2015). Details 
regarding the soft tissue measurements were described in a previ-
ous publication (de Siqueira et al., 2017). All patients received a 1 g 
dose of amoxicillin and an 8 mg dose of betamethasone 1 hr before 
surgery. Standardized surgical procedures were performed by the 
same experienced surgeon (PGFS) for all patients. Fifty-five inter-
nal tapered implants (sandblasted and acid-etched surface, Titamax 
CM, Neodent, Curitiba, PR, Brazil) were placed during this RCT (five 
implants per patient). The implants were placed at least 3.5–5 mm 
anterior to the mental foramens. Implant diameters (3.5–4.3 mm) 
and length (10–13 mm) were selected based on the local bone avail-
ability to ensure a minimum of 1mm supporting bone around the 
implants. An insertion torque ≥ 45 Ncm was required for immediate 
loading (Thome et al., 2015). In order to avoid excessive osseo-com-
pression, maximum torque was limited to 60 Ncm. A wider diameter 
implant was used when the initial insertion torque was <45 Ncm. 
Twenty-eight implants were placed equicrestally (G1), and 27 im-
plants were placed 1–3 mm subcrestally (G2) (Figure 2). The sub-
crestal placement depth was assessed using the implant insertion 
handle (Neodent). The surgical procedure and drilling protocol were 
standardized for both groups. The prosthetic abutment height (mini 
conical abutments, Neodent) was selected taking into consideration 
that the prosthetic margin should be placed at the level of the mu-
cosa. Healing caps were placed and flaps were closed without ten-
sion using 5/0 interrupted Nylon sutures (Ethicon US, Somerville, NJ, 
USA). All patients were prescribed 0.12% chlorhexidine digluconate 
rinse (Noplak, Daudt, Rio de Janeiro, RJ, Brazil), 500 mg of amoxicil-
lin (twice a day for 7 days), and 500 mg acetaminophen (if needed 
for pain control).
2.6 | Prosthetic procedure
Prosthetic procedures and prostheses fabrication followed a previ-
ously described technique and were performed by the same pros-
thodontist (RACS) (Borges, Dias Pereira, Thome, Melo, & de Mattias 
Sartori, 2010; Thome et al., 2015). New maxillary complete dentures 
were fabricated for all patients. A cast rigid bar was fabricated for 
the mandibular hybrid prosthesis using a passive fitting technique 
(Lee et al., 2012). The framework bar was waxed over a dimension-
ally larger brass cylinder than the titanium cylinder that was later 
cemented to the framework using resin cement (Panavia F; Kuraray 
Co., Ltd, Tokyo, Japan). Acrylic resin and acrylic teeth were then used 
to fabricate the mandibular hybrid full-arch implant-fixed prosthesis. 
Forty-eight hours after implant installation healing caps were re-
moved, and the screw-retained prostheses were delivered. Patients 
were given oral hygiene instructions and returned for follow-up 
10 days after surgery. All prostheses were then removed for suture 
removal. Following surgical treatment, the patients were recalled at 
4, 8, 12, and 16 weeks, as well as at 8 months, for control and oral 
hygiene instructions. Recall visits were then every 6 months for re-
inforcement of oral hygiene instructions and supragingival plaque 
removal during a follow-up period of 5 years. Maintenance protocol 
at the ILAPEO College consists of prosthesis removal and debride-
ment of implant surfaces with manual Teflon curettes and gently 
powered rubber prophy cups. Prosthesis was polished with rubber 
cups for plaque removal. Patients were encouraged to use soft stiff-
ness toothbrushes on prosthetic surfaces and abutment necks. They 
were also thoroughly instructed on how to use superfloss® (Oral-B, 
Procter and Gamble Co, Cincinnati, USA) for cleaning under prosthe-
sis and around implants.
2.7 | Follow-up measurements
The clinical measurements and radiographic examinations were per-
formed at baseline, 4, 8, and 60 months after surgery. All patients re-
turned for the follow-ups, and the previously described procedures 
for prosthesis removal and soft tissue measurements were repeated. 
Pocket probing depth (PPD) was measured to the nearest millim-
eter using a 10-mm graduated periodontal probe (Williams probe, 
Millenium, São Caetano do Sul, SP, Brazil), at the mid-facial, mid-lingual, 
and interproximal surfaces of each implant (4 sites) (Figure 3). The peri-
odontal probe was also used to evaluate peri-implant health status and 
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the degree of soft tissue recession in relation to the abutment position, 
defined as the distance from the prosthetic abutment margin to the 
mucosal margin (Renvert, Persson, Pirih, & Camargo, 2018). Bleeding 
on probing score (BOP%) was assessed as the proportion of bleed-
ing sites (dichotomous yes/no evaluation) when stimulated by manual 
probing with a controlled (∼25 g) force to the bottom of the sulcus/
pocket at the four sites previously described. Intraoral radiographs 
were taken in high resolution mode (Heliodent Vario, Sirona, Bensheim, 
Germany) with the aid of a film holder (de Mattias Sartori, Silveira Junior, 
Fontao, & Gloria Chiarello de Mattos, 2014) using the parallel technique 
(Figure 4). Radiographs were taken by the same operator immediately 
(baseline) after implant placement and at the 4-, 8-, and 60-month 
follow-up returns (T0, T4, T8, and T60, respectively) (Figure 5). Intraoral 
radiographs at all time points allowed for the evaluation of CB changes 
and specialized software (Sidexis XG 2.5, Sirona) was used for linear 
measurements of CB changes (de Siqueira et al., 2017). Measurements 
of the equicrestal implants were performed from the bone crest to the 
implant-abutment interface. Measurements on subcrestal implants 
were performed from the most apical region of the radiolucent image 
to the implant-abutment interface as described in previous article de 
Siqueira et al. (2017). One calibrated examiner performed all the meas-
urements. Examiner error was evaluated by measuring mesial bone 
level for all implants at two time points (2 weeks interval). Agreement 
of values was observed, with no significant systematic error in the 
F I G U R E  1   Patient screening, 
recruitment, allocation, and follow-up 
chart according to the Consolidated 
Standards of Reporting Trials (CONSORT) 
criteria
F I G U R E  2   Implant placement depth 
configuration (equicrestal: 1, 2, and 3; 
subcrestal: 4 and 5). (a) frontal view; (b) 
occlusal view
(a) (b)
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measurement (p = .108, Wilcoxon test). Dahlberg's error (0.005) indi-
cated low variability in both measurements.
2.8 | Statistical analysis
Mean CB changes and VMT among subcrestal and equicrestal implants 
were statistically analyzed using specialized software with the “f1.ld.f1” 
function of the software package (SAS University Edition, Cary, NC, 
USA). Mean, standard deviation, median, and range were calculated for 
each analysis. Statistical analysis of different implant placement depths 
(equicrestal or subcrestal) and VMT at the three evaluation times (4, 8, 
and 60 months) was performed using rank-based ANOVA-type statisti-
cal test (a = 0.05) (Brunner, Domhof, & Langer, 2002). Treatment, time, 
and interaction between these two factors were tested considering 
the dependence structure of data (treatment and time clustered within 
patient). The effect of treatment (subcrestal and equicrestal) with BOP 
and peri-implant mucositis was assessed by fitting multilevel logistic 
regression models and using the Wald test (level 1: implants; level 2: 
patients). A sample size calculation (80% power; significance level of 
.05) determined that 28 implants per group were required to detect 
a 0.3 mm difference in CB changes using a two-tailed Student's t test.
3  | RESULTS
A total of 11 patients from the previously published 8-month data (de 
Siqueira et al., 2017) completed a mean follow-up time of 5.1 ± 0.1 years. 
No patients dropped out or were excluded during the follow-up time, 
and all patients returned for the scheduled follow-up evaluations. No 
implants or prosthesis were lost within the 60-month evaluation pe-
riod, resulting in a 100% implant and prosthesis survival rate.
CB loss for the two groups at different measurement times (4-, 
8-, and 60-month follow-up) is presented in Table 1. Equicrestal 
F I G U R E  3   Measurement of soft tissue recession from the 
abutment to the mucosal margin at the T60 follow-up
F I G U R E  4   Standardized intraoral 
digital radiographs of equicrestal and 
subcrestal implants at baseline, 4, 8, and 
60 months
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implants showed higher CB loss than subcrestal implants without a 
statistically significant difference (p > .05). Significant CB loss within 
each group was found when comparing baseline to each time point. 
However, no significant differences were observed between T8 and 
T60 in none of the groups. Moreover, thread exposure occurred only 
in one implant in the equicrestal group, and there were no thread 
exposures in the subcrestal group.
Soft tissue recession was assessed at the 60-month eval-
uation for the two implant placement depth groups (Table 2). 
Implant placement depths had no effect on the amount of soft 
F I G U R E  5   Radiographic measurement 
of crestal bone levels at baseline, 4, 8, and 
60 months for: (a) equicrestal implants; (b) 
subcrestal implants
TA B L E  1   Crestal bone changes for equi- and subcrestal implants at 4-, 8-, and 60-month evaluations (T4, T8, and T60)
Evaluation times
Equicrestal Implants Subcrestal Implants
p-Value* 
(Equicrestal × Subcrestal)Mean ± SD Median (min; max) Mean ± SD Median (min; max)
T4 0.86 ± 0.55 0.85 (0.23; 1.86) 0.50 ± 0.35 0.47 (0.15; 1.38) .063
T8 1.03 ± 0.60 1.03 (0.19; 1.90) 0.66 ± 0.38 0.61 (0.19; 1.52)
T60 0.99 ± 0.55 0.83 (0.46; 2.64) 0.80 ± 0.52 0.70 (0.29; 2.61)
p-Value* (T4/T8/T60) .003  
Note: p-Value for interaction between implant type and time: 0.439. T4/T8: p < .001, T4/T60: p = .001, T8/T60: p = .334.
Abbreviation: SD, standard deviation.
*Rank-based ANOVA tests, p < .05. 
TA B L E  2   Soft tissue recession at the 4-, 8-, and 60-month evaluations
Implant surface Time
Equicrestal Implants Subcrestal Implants
p-Value* 
(Equicrestal × Subcrestal)Mean ± SD Median (min; max) Mean ± SD Median (min; max)
Buccal and lingual T4 0.30 ± 0.35 0.42 (−0.50; 0.67) 0.47 ± 0.32 0.50 (0; 1.13) .189
T8 0.30 ± 0.46 0.25 (−0.50; 1.17) 0.60 ± 0.52 0.42 (−0.08; 2.00)
T60 1.14 ± 0.54 1.00 (0.50; 3.00) 1.06 ± 0.35 1.00 (0.50; 2.00)
p-Value* (T4/T8/
T60)
 <0.001  
Mesial and distal T4 0.26 ± 0.33 0.25 (−0.13; 0.92) 0.42 ± 0.52 0.17 (−0.38; 1.08) .525
T8 0.13 ± 0.32 0 (−0.25; 0.67) 0.33 ± 0.70 0.25 (−0,62; 1.62)
T60 1.26 ± 0.48 1.00 (0.50; 3.00) 1.21 ± 0.40 1.00 (0.75; 2.25)
p-Value* (T4/T8/
T60)
 <.001  
Note: p-Value for interaction between implant type and time: 0.273 (buccal and lingual); 0.535 (mesial and distal). Buccal and lingual: T4/T8: p = .534, 
T4/T60: p < .001, T8/T60: p < .001. Mesial and distal: T4/T8: p = .138, T4/T60: p < .001, T8/T60: p < .001.
Abbreviation: SD, standard deviation.
*Rank-based ANOVA tests, p < .05. 
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tissue recession (p > .05); however, the analyses within each group 
showed significant soft tissue recession at the different measure-
ment times (T4, T8, and T60) (p < .05). VMT did not influence the 
amount of soft tissue recession when evaluated independently of 
implant placement depth within or between groups (Tables 3 and 
4; p > .05).
The abutment heights utilized in the study and average peri-im-
plant CB loss at the 60-month evaluation are displayed in Table 5. 
Mean PPD was 2.9 mm for G1 (equicrestal implants) and 2.7 mm 
for G2 (subcrestal implants). BOP scores as at T4, T8, and T60 were 
23.1%, 21.4%, and 24.5%, respectively. BOP scores as at T4, T8, 
and T60 were 23.1%, 21.4%, and 24.5%, respectively. No statisti-
cally significant difference was found for BOP scores between G1 
and G2 groups at all time points (p = .926; p = .661 and p = .926, 
respectively).
Progressive bone loss based on radiographic bone level assess-
ment along with signs of inflammation was noted in 2 (equicrestal 
group) of the 55 implants after 60-months following the delivery of 
the prosthesis. These implants were then diagnosed with peri-im-
plantitis (peri-implantitis incidence in this study was 3.6% at the 
implant level and 9% at the patient level). Peri-implant mucositis af-
fected 9 out of the 55 implants (16.4% at the implant level and 54% 
at patient level) with no statistically significant difference between 
G1 and G2 groups (p = .588) (Berglundh et al., 2018; Renvert et al., 
2018).
4  | DISCUSSION
The short- (4 and 8 months) and long-term (5 years) clinical out-
comes suggested that implant placement level (equi- or sub-
crestally) did not affect the amount of CB changes and both 
placements can be considered a reliable approach for implant 
supported fixed prosthesis in the lower arch. To our knowledge, 
this was the first RCT study which assessed the 5-year clinical 
outcomes of equi- and subcrestally implant placement in a split-
mouth design.
Different bone level measurements were needed for the equi-
crestal and subcrestal groups because of the different implant 
placement depths and resulting bone level configuration. Since each 
implant was compared to itself at baseline and at the 60-month eval-
uation, CB changes between the different groups were properly as-
sessed. Any reduction in the bone level compared to the baseline 
level was considered CB loss.
The results found in this RCT showed there was no signifi-
cant difference in CB changes between the two depths of implant 
placement. Although subcrestal implants had slightly less CB loss 
when compared to equicrestal implants, no statistically significant 
difference was noted. This is in agreement with previous studies 
that demonstrated no statistically significant difference between 
the two placement depths tested (Al Amri et al., 2017; Koh et al., 
2011; Koutouzis et al., 2014; Palaska et al., 2016). Although the 
placement of subcrestal implants was suggested to minimize bone 
resorption (Barros, Novaes, Muglia, Iezzi, & Piattelli, 2010; Fetner 
et al., 2015; Novaes et al., 2009; Pontes et al., 2008; Saleh et al., 
2018; Vervaeke et al., 2018; Weng, Nagata, Leite, de Melo, & 
Bosco, 2011), a study conducted by Pellicer and coworkers found 
greater bone loss for subcrestal implants (Pellicer-Chover et al., 
2016).
Although no statistical difference in CB levels was found be-
tween subcrestal and equicrestal placement, subcrestal implant 
placement was able to avoid thread exposure for all implants 
after 5 years. The clinical relevance of this result is that subcrestal 
placement may reduce the risk of having peri-implantitis by min-
imizing rough surface exposure (Monje, Galindo-Moreno, Tozum, 
Suarez-Lopez del Amo, & Wang, 2016; Schwarz et al., 2017). A 
similar finding was reported by Vervaeke and coworkers in a 2-year 
follow-up study (Vervaeke et al., 2018) and in a RCT with 3-year 
follow-up using platform-switched implants (Al Amri et al., 2017). 
Once exposed, implants with rough surfaces can facilitate biofilm 
formation (Pistilli et al., 2018; Teughels, Van Assche, Sliepen, & 
Quirynen, 2006).
One group found no difference for subcrestal implant place-
ments of 0.5 or 1.5 mm and made a logical consideration that it might 
be sensible to place implants at a depth of 0.5 mm in order to be able 
to fully use 1 mm more of bone support, especially for situations of 
limited bone heights (Gualini et al., 2017). However, the decision to 
place a longer implant in a crestal position may not always be the 
most ideal treatment decision since the risk of peri-implantitis may 
be increased with exposure of rough implant surfaces. In addition, 
recent systematic reviews showed that even short implants present 
similar CB changes and survival rates compared to longer implants 
(Ravida et al., 2019) and an implant/crown ratio up to 2.2 does not 
lead to increased complications (Meijer, Boven, Delli, & Raghoebar, 
2018).
The vertical position of the implant-abutment interface, al-
though of extreme importance, does not seem to be the only cause 
of bone loss, and other factors such as platform-switching, types 
of connection, timing of abutment placement and height, and soft 
tissues characteristics should all be taken in account. Compared to 
non-mismatched implant-abutment connection, internal tapered 
implants with platform-switching are expected to have lower bone 
loss due to a reduced microgap at the implant-abutment interface 
leading to less bacterial leakage and lower stress in the surround-
ing bone (Castro et al., 2014; D'Ercole et al., 2014). Therefore, im-
plants with non-mismatched connections are not recommended to 
be placed subcrestally (Broggini et al., 2003; Hermann, Cochran, 
Nummikoski, & Buser, 1997; Weng, Nagata, Bosco, & de Melo, 
2011).
Adequate (usually ≥ 2mm) soft tissue thickness and keratinized 
mucosa width have been reported to lead to healthier peri-implant 
soft and hard tissues (Grischke et al., 2019), as well as to promote 
less bone loss, improved oral hygiene (Perussolo et al., 2018), and 
better mucosal esthetics (Bonino et al., 2018). A subanalysis per-
formed in the present study revealed that VMT <2 mm did not 
affect the bone remodeling around equi- and subcrestal implants 
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since no statistically significant difference was found. This find-
ing is in agreement with a previous study (Canullo et al., 2017), 
which concluded that with bone-level platform-switching im-
plants, the tissue thickness appears to have a negligible effect on 
crestal bone loss. Linkevicius and coworkers in 2010 (Linkevicius, 
Apse, Grybauskas, & Puisys, 2010) reported that in presence of 
thin tissue (<2 mm), platform-switching did not preserve crestal 
bone better than a traditional implant-abutment connection. More 
recently, the same group reported that less bone loss occurred in 
thick tissues (>2.5 mm) when compared to medium (2.0–2.5 mm) 
and thin (<2 mm) thicknesses (Linkevicius et al., 2018). In the pres-
ent study, subanalysis of the effect of keratinized tissue width 
within the sub- and equicrestal groups was not reported as KM 
was ≥2 mm in the majority of the implants evaluated. The homo-
geneous distribution of KM ≥2 mm could have also contributed 
to the overall favorable outcomes reported. In addition, most of 
the crestal bone loss occurred in the first months of follow-up 
and eventually stabilized with little changes occurring toward the 
end of the follow-up period. Perhaps this can be explained by the 
healthy (absence of major systemic diseases and non-smokers) and 
well-maintained population recruited for this study.
Abutment height has been recently reported to influence the 
supracrestal tissues establishment around implants irrespective of 
vertical mucosal thickness (Spinato et al., 2019). In the present study, 
we observed greater peri-implant bone loss when short abutments 
(1.5 mm) were utilized to restore equicrestally positioned implants 
in areas with thinner mucosa. Similar findings have been previously 
published by other groups (Galindo-Moreno et al., 2016; Novoa et 
al., 2017; Pico et al., 2019; Spinato et al., 2019). However, further sta-
tistical analysis regarding abutment height could not be performed 
due to the restricted sample size which could be considered a limita-
tion of the present study.
Deeper implant placement could potentially be linked to deeper 
pocketing and greater inflammation. However, in the present study, 
TA B L E  3   Soft tissue recession for the two levels of baseline vertical mucosal thickness measured at the 4-, 8-, and 60-month evaluations
Implant surface Time
Vertical Mucosa Thickness ≥ 2 mm Vertical Mucosa Thickness < 2 mm
p-Value* 
(≥2 mm × <2mm)Mean ± SD Median (min; max) Mean ± SD Median (min; max)
Buccal and lingual T4 0.29 ± 0.28 0.30 (−0.25; 0.75) 0.50 ± 0.41 0.50 (−0.17; 1.25) .445
T8 0.41 ± 0.41 0.25 (−0.13; 1.25) 0.50 ± 0.44 0.50 (−0.17; 1.20)
T60 1.13 ± 0.41 1.00 (0.50; 2.00) 1.07 ± 0.50 1.00 (0.50; 3.00)
p-Value* (T4/T8/T60)  <.001  
Mesial and distal T4 0.25 ± 0.37 0.13 (−0.20; 0.81) 0.46 ± 0.55 0.25 (−0.17; 1.50) 0.485
T8 0.19 ± 0.41 0.25 (−0.50; 0.75) 0.39 ± 0.51 0.42 (−0.10; 1.50)
T60 1.22 ± 0.35 1.00 (0.75; 2.00) 1.25 ± 0.51 1.00 (0.50; 3.00)
p-Value* (T4/T8/T60)  <.001  
Note: p-Value for interation between vertical mucosa thickness and time: 0.272 (buccal and lingual); 0.520 (mesial and distal). Buccal and lingual: T4/
T8: p = .391, T4/T60: p < .001, T8/T60: p < .001. Mesial and distal: T4/T8: p = .563, T4/T60: p < .001, T8/T60: p < .001.
Abbreviation: SD, standard deviation.
*Rank-based ANOVA tests, p < .05. 
TA B L E  4   Crestal bone changes for two levels of vertical mucosal thickness at 4-, 8-, and 60-month evaluations for equi- and subcrestal 
implants
Implants Time
Vertical mucosa thickness ≥ 2 mm Vertical mucosa thickness < 2 mm
p-Value* 
(≥2 mm × <2 mm)Mean ± SD Median (min; max) Mean ± SD Median (min; max)
Subcrestal (≥2 mm; n = 14) 
(<2 mm; n = 13)
T4 0.44 ± 0.43 0.28 (0; 1.59) 0.62 ± 0.56 0.45 (0.06; 1.73) .457
T8 0.63 ± 0.48 0.43 (0.05; 1.54) 0.76 ± 0.56 0.62 (0.18; 1.82)
T60 0.87 ± 0.61 0.70 (0.33; 2.61) 0.72 ± 0.39 0.71 (0.29; 1.54)
p-Value* (T4/T8/T60)  <.001  
Equicrestal (≥2 mm; 
n = 11) (<2 mm; n = 17)
T4 1.05 ± 0.65 1.12 (0.12; 2.54) 0.72 ± 0.62 0.51 (0.08; 2.06) .272
T8 1.23 ± 0.58 1.27 (0.51; 2.44) 0.88 ± 0.76 0.64 (0.10; 2.27)
T60 1.01 ± 0.64 0.85 (0.51; 2.64) 0.99 ± 0.50 0.81 (0.46; 2.23)
p-Value* (T4/T8/T60)  .210  
Note: p-Value for interation between vertical mucosa thickness and time: 0.195 (subcrestal); 0.472 (equicrestal). Subcrestal: T4/T8: p < .001, T4/T60: 
p < .001, T8/T60: p = .183.
Abbreviation: SD, standard deviation.
*Rank-based ANOVA tests, p < .05. 
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deeper probing measurements indicative of peri-implant pocket-
ing and signs of peri-implant inflammation along with progressive 
peri-implant bone loss were found in 2 equicrestal implants at the 
5-year follow-up. No peri-implantitis was diagnosed for any of the 
subcrestal implants. The incidence of peri-implantitis of 3.63% at im-
plant level and 9.1% at the patient level were lower when compared 
to the other reported data (Derks et al., 2016; Derks & Tomasi, 2015; 
French, Grandin, & Ofec, 2019).
Soft tissue recession was not significantly different at the 4- and 
8-month timepoints compared to baseline, but significantly increased 
by the end of the 60-month follow-up period. This phenomenon could 
potentially be explained by the fact that alveoloplasty was performed 
before implant placement and this might result in extra tissue thick-
ness that gradually contracted after bone remodeling and biological 
width (supracrestal fiber attachment) establishment (Berglundh & 
Lindhe, 1996). There was no significant difference in soft tissue reces-
sion between sub- and equicrestal implants and VMT did not influence 
the outcome. Since CB levels around all implants were similar, and ac-
cording to a previous classical study (Kan, Rungcharassaeng, Umezu, 
& Kois, 2003) the crestal bone level dictates the level of the mucosal 
margin, this may explain the absence of a correlation between soft tis-
sue recession and different placement depths.
One limitation of this study is that a wide range of subcrestal 
implant placement (1–3 mm) was selected to achieve enough pri-
mary stability. Ideally, we should have evaluated the impact of each 
implant depth on bone loss, although due to the small number of 
patients it was not possible. Additionally, the application of an imme-
diate loading protocol with the one abutment–one time concept may 
present advantages compared to two stages protocols regarding 
crestal bone changes, and therefore caution should be taken when 
analyzing the present outcome.
5  | CONCLUSION
Within the limitations found in the present study, different im-
plant placement depths and vertical mucosal thickness showed 
no statistically significant influence on crestal bone level changes 
and soft tissue recession after 5 years of follow-up. However, 
subcrestal implant placement had less bone loss and resulted in 
no implant thread exposure, whereas with equicrestal placement, 
thread exposure occurred in one implant after 5-year follow-up. It 
is, therefore, speculated that a subcrestal implant placement of at 
least 1 mm can prevent possible biological complications due to 
implant rough surface exposure.
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